# A Clinical Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on the Development of Allergic Manifestations in Infants at High Risk of Developing Allergy

> **NCT03062995** · PHASE3 · WITHDRAWN · sponsor: **Nutricia Research**

## Conditions studied

- Immunity

## Interventions

- **OTHER:** Infant Formula with added synbiotics
- **OTHER:** Standard Infant formula

## Key facts

- **NCT ID:** NCT03062995
- **Lead sponsor:** Nutricia Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-06
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study design not adequate anymore
- **Last updated:** 2021-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03062995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03062995, "A Clinical Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on the Development of Allergic Manifestations in Infants at High Risk of Developing Allergy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03062995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*